Sar in the alkoxy lactone series:: The discovery of DFP, a potent and orally active COX-2 inhibitor

被引：49

作者：

Leblanc, Y

Roy, P

Boyce, S

Brideau, C

Chan, CC

Charleson, S

Gordon, R

Grimm, E

Guay, J

Léger, S

Li, CS

Riendeau, D

Visco, D

Wang, Z

Webb, J

Xu, LJ

Prasit, P

机构：

[1] Merck Frosst Ctr Therapeut Res, Pointe Claire, PQ H9R 4P8, Canada

[2] Merck Res Labs, Harlow, Essex, England

[3] Merck Res Labs, Rahway, NJ USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1999年 / 9卷 / 15期

关键词：

D O I：

10.1016/S0960-894X(99)00365-0

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Extensive SAR has been established in the alkoxy lactone series and this has lead to the discovery of DFP (5,5-dimethyl-3-(2-propoxy)-4-methanesulfonylphenyl)-2-(5H)-furanone), a potent COX-2 inhibitor exhibiting in vivo efficacy in all models studied. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.

引用

页码：2207 / 2212

页数：6

共 50 条

[41] An Efficient Asymmetric Synthesis of A Potent COX-2 Inhibitor L-784,512
Tan, L.
Chen, C.-Y.
Larsen, R. D.
Verhoeven, T. R.
Tetrahedron Letters, 39 (23):
[42] Biphenylsulfonamide endothelin a receptor antagonists: Discovery and SAR of potent, selective and orally active second generation antagonists.
Murugesan, N
Gu, ZX
Spergel, S
Young, M
Chen, P
Liu, ECK
Zhang, RG
Marino, A
Morrison, RA
Webb, ML
Moreland, S
Barrish, JC
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A108 - A108
[43] Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMR
Petros, Andrew M.
Huth, Jeffrey R.
Oost, Thorsten
Park, Cheol-Min
Ding, Hong
Wang, Xilu
Zhang, Haichao
Nimmer, Paul
Mendoza, Renaldo
Sun, Chaohong
Mack, Jamey
Walter, Karl
Dorwin, Sarah
Gramling, Emily
Ladror, Uri
Rosenberg, Saul H.
Elmore, Steven W.
Fesik, Stephen W.
Hajduk, Philip J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) : 6587 - 6591
[44] SELECTIVE CYCLOOXYGENASE INHIBITORS - NOVEL 4-SPIRO 1,2-DIARYLCYCLOPENTENES ARE POTENT AND ORALLY-ACTIVE COX-2 INHIBITORS
REITZ, DB
HUANG, HC
LI, JJ
GARLAND, DJ
MANNING, RE
ANDERSON, GD
GREGORY, SA
KOBOLDT, CM
PERKINS, WE
SEIBERT, K
ISAKSON, PC
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (08) : 867 - 872
[45] DISCOVERY OF A NOVEL AND POTENT CHOLESTEROL ABSORPTION INHIBITOR (CAI) AS PROMISING ORALLY ACTIVE LIPID LOWERING DRUG
Kanou, M.
Nisiwaki, Y.
Nakano, A.
Sugimoto, Y.
Yamanaka, Y.
Kondo, S.
ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
[46] Discovery and preclinical characterization of BMN 673, a highly potent and orally active PARP inhibitor as an anticancer agent
Wang, Bing
Chu, Daniel
Shen, Yuqiao
Feng, Ying
Myers, Peter
Post, Leonard
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[47] Novel 1,2-diarylcyclobutenes: Selective and orally active COX-2 inhibitors.
Frenette, R
Friesen, RW
Dube, D
Fortin, R
Prescott, S
Cromlish, W
Greig, G
Kargman, S
Wong, E
CHan, CC
Gordon, R
Xu, L
Riendeau, D
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 70 - MEDI
[48] Orally active small molecule inhibitors of TNF-α and COX-2 for the treatment of inflammatory disorders
Pandey, B
Balse, P
Nag, A
Gutula, S
Neogi, P
Nag, B
Dey, D
FASEB JOURNAL, 2004, 18 (04): : A455 - A455
[49] Discovery of potent and orally active 3-alkoxy-5-phenoxy-N-thiazolyl benzamides as novel allosteric glucokinase activators
Iino, Tomoharu
Tsukahara, Daisuke
Kamata, Kenji
Sasaki, Kaori
Ohyama, Sumika
Hosaka, Hideka
Hasegawa, Takuro
Chiba, Masato
Nagata, Yasufumi
Eiki, Jun-ichi
Nishimura, Teruyuki
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (07) : 2733 - 2743
[50] Discovery of DS-5272 as a promising candidate: A potent and orally active p53-MDM2 interaction inhibitor
Miyazaki, Masaki
Uoto, Kouichi
Sugimoto, Yuuichi
Naito, Hiroyuki
Yoshida, Keisuke
Okayama, Tooru
Kawato, Haruko
Miyazaki, Masaya
Kitagawa, Mayumi
Seki, Takahiko
Fukutake, Setsuko
Aonuma, Masashi
Soga, Tsunehiko
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (10) : 2360 - 2367

← 1 2 3 4 5 →